$QNCX
Quince Therapeutics, Inc.

2021 Q4 Form 10-Q Financial Statement

#000095017021002495 Filed on October 29, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.330M $7.640M $7.060M
YoY Change 66.6% 54.97% 68.5%
% of Gross Profit
Research & Development $15.21M $14.04M $14.72M
YoY Change -4.1% -17.34% 4.49%
% of Gross Profit
Depreciation & Amortization $80.00K $90.00K $80.00K
YoY Change 0.0% 0.0% 0.0%
% of Gross Profit
Operating Expenses $23.54M $21.68M $21.78M
YoY Change 12.9% -1.07% 19.22%
Operating Profit -$21.68M -$21.78M
YoY Change -1.07% 19.22%
Interest Expense $110.0K $130.0K $160.0K
YoY Change -63.33% -68.29% -75.76%
% of Operating Profit
Other Income/Expense, Net $40.00K -$157.0K -$131.0K
YoY Change
Pretax Income -$23.40M -$21.71M -$21.75M
YoY Change 13.81% 0.93% 23.51%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$23.40M -$21.71M -$21.75M
YoY Change 13.81% 0.93% 23.52%
Net Earnings / Revenue
Basic Earnings Per Share -$0.73
Diluted Earnings Per Share -$0.78 -$0.73 -$0.74
COMMON SHARES
Basic Shares Outstanding 29.88M 29.69M 29.59M
Diluted Shares Outstanding 29.77M

Balance Sheet

Concept 2021 Q4 2021 Q3 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $66.53M $114.4M $130.0M
YoY Change -50.28% -16.97% -10.07%
Cash & Equivalents $29.45M $62.21M $74.05M
Short-Term Investments $37.08M $52.21M $55.90M
Other Short-Term Assets $367.0K $495.0K $438.0K
YoY Change -47.12% -21.3% -50.4%
Inventory
Prepaid Expenses $333.0K $472.0K $459.0K
Receivables
Other Receivables
Total Short-Term Assets $111.7M $119.4M $135.8M
YoY Change -19.0% -16.47% -10.39%
LONG-TERM ASSETS
Property, Plant & Equipment $263.0K $303.0K $390.0K
YoY Change -38.41% -39.4% -70.0%
Goodwill $0.00
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments $19.90M $26.10M $23.50M
YoY Change -60.59% -56.57% -64.45%
Other Assets $194.0K $193.0K $145.0K
YoY Change 397.44% -7.66% -27.5%
Total Long-Term Assets $21.56M $27.99M $25.55M
YoY Change -58.23% -54.63% -62.21%
TOTAL ASSETS
Total Short-Term Assets $111.7M $119.4M $135.8M
Total Long-Term Assets $21.56M $27.99M $25.55M
Total Assets $133.2M $147.4M $161.4M
YoY Change -29.68% -27.97% -26.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.911M $2.880M $7.193M
YoY Change 38.14% -33.16% 41.04%
Accrued Expenses $9.311M $11.27M $11.34M
YoY Change -30.73% -6.83% 31.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.22M $14.15M $18.54M
YoY Change -16.32% -13.74% 35.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $400.0K $600.0K $800.0K
YoY Change 100.0% 200.0% 700.0%
Total Long-Term Liabilities $400.0K $600.0K $800.0K
YoY Change 100.0% 200.0% 700.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.22M $14.15M $18.54M
Total Long-Term Liabilities $400.0K $600.0K $800.0K
Total Liabilities $14.64M $14.76M $19.31M
YoY Change -14.89% -11.59% 40.95%
SHAREHOLDERS EQUITY
Retained Earnings -$236.6M -$213.2M -$191.5M
YoY Change 61.33% 69.07%
Common Stock $355.3M $345.8M $333.5M
YoY Change 11.51% 10.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $118.6M $132.7M $142.1M
YoY Change
Total Liabilities & Shareholders Equity $133.2M $147.4M $161.4M
YoY Change -29.68% -27.97% -26.37%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021 Q2
OPERATING ACTIVITIES
Net Income -$23.40M -$21.71M -$21.75M
YoY Change 13.81% 0.93% 23.52%
Depreciation, Depletion And Amortization $80.00K $90.00K $80.00K
YoY Change 0.0% 0.0% 0.0%
Cash From Operating Activities -$14.42M -$17.34M -$17.56M
YoY Change 8.58% 40.18% 22.03%
INVESTING ACTIVITIES
Capital Expenditures $40.00K $0.00 $100.0K
YoY Change 300.0% -100.0% 900.0%
Acquisitions
YoY Change
Other Investing Activities $20.96M $770.0K $5.720M
YoY Change 32.32% -92.59% -196.46%
Cash From Investing Activities $20.92M $760.0K $5.630M
YoY Change 32.15% -92.67% -194.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 990.0K 4.710M 670.0K
YoY Change 1880.0% 5133.33% -24.72%
NET CHANGE
Cash From Operating Activities -14.42M -17.34M -17.56M
Cash From Investing Activities 20.92M 760.0K 5.630M
Cash From Financing Activities 990.0K 4.710M 670.0K
Net Change In Cash 7.490M -11.87M -11.26M
YoY Change 188.08% 521.47% -42.11%
FREE CASH FLOW
Cash From Operating Activities -$14.42M -$17.34M -$17.56M
Capital Expenditures $40.00K $0.00 $100.0K
Free Cash Flow -$14.46M -$17.34M -$17.66M
YoY Change 8.8% 39.95% 22.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001662774
crtx Entity Date Of Incorporation
EntityDateOfIncorporation
2012-06
CY2019Q2 crtx Operating Lease Termination Month And Year
OperatingLeaseTerminationMonthAndYear
2021-07
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q2 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38890
dei Entity Registrant Name
EntityRegistrantName
Cortexyme, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1024039
dei Entity Address Address Line1
EntityAddressAddressLine1
269 East Grand Ave.
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
910-5717
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
CRTX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29877608
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62207000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66841000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
52205000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
66979000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5015000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4042000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
119427000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
137862000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
303000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1352000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
674000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
26141000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
50464000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
193000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39000
CY2021Q3 us-gaap Assets
Assets
147416000
CY2020Q4 us-gaap Assets
Assets
189466000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2880000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3555000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11274000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14154000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16996000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13441000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
610000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
208000
CY2021Q3 us-gaap Liabilities
Liabilities
14764000
CY2020Q4 us-gaap Liabilities
Liabilities
17204000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29867263
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29867263
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29543222
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29543222
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
30000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
29000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
345751000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
318574000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
71000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
313000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-213200000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146654000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
132652000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
172262000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
147416000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
189466000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14038000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16983000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45582000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45450000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7639000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4929000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21192000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12591000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
21677000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
21912000
us-gaap Operating Expenses
OperatingExpenses
66774000
us-gaap Operating Expenses
OperatingExpenses
58041000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21677000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21912000
us-gaap Operating Income Loss
OperatingIncomeLoss
-66774000
us-gaap Operating Income Loss
OperatingIncomeLoss
-58041000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
128000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
406000
us-gaap Investment Income Interest
InvestmentIncomeInterest
515000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1747000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-157000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-287000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-21706000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-21506000
us-gaap Net Income Loss
NetIncomeLoss
-66546000
us-gaap Net Income Loss
NetIncomeLoss
-56294000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-64000
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-198000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-260000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
453000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21752000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21704000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-66788000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-55841000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.73
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.73
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.25
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.94
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29767376
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29488739
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29637328
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29066006
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
142080000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4706000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7618000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-46000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-21706000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
132652000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
205467000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
90000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4158000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-198000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-21506000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
188011000
crtx Finance Lease Right Of Use Asset Depreciation Expense
FinanceLeaseRightOfUseAssetDepreciationExpense
170000
crtx Finance Lease Right Of Use Asset Depreciation Expense
FinanceLeaseRightOfUseAssetDepreciationExpense
173000
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
132144000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
79000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
172262000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5818000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21360000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-242000
us-gaap Net Income Loss
NetIncomeLoss
-66546000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
132652000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
115478000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
117628000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1235000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9511000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
453000
us-gaap Net Income Loss
NetIncomeLoss
-56294000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
188011000
us-gaap Profit Loss
ProfitLoss
-66546000
us-gaap Profit Loss
ProfitLoss
-56294000
crtx Non Cash Rent Expense
NonCashRentExpense
199000
crtx Non Cash Rent Expense
NonCashRentExpense
275000
us-gaap Share Based Compensation
ShareBasedCompensation
21360000
us-gaap Share Based Compensation
ShareBasedCompensation
9511000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
260000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
247000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-679000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-429000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
973000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1044000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
154000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-8000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-675000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1234000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2664000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6004000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48514000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37542000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
35778000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
183356000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
73947000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
115141000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
136000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
38033000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68257000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
32000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5818000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1235000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
117628000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5818000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
118831000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4634000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13032000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66841000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51214000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62207000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64246000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1254000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
620000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-213200000
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
114400000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
26100000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
27000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
132196000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
148594000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:8.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and expenses, as well as related disclosure of contingent assets and liabilities. The most significant estimates used in the Company’s consolidated financial statements relate to the stock-based awards and other issuances, accruals for research and development costs, useful lives of long-lived assets, stock-based compensation and related assumptions, the incremental borrowing rate for leases and income tax uncertainties, including a valuation allowance for deferred tax assets; and contingencies. The Company bases its estimates on historical experience and on various other market specific and other relevant assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from the Company’s estimates.</span></p>
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
132196000
CY2021Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
53850000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
52205000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
26141000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1352000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
674000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
737000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
238000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
610000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
208000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1347000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
446000
CY2021Q3 crtx Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
557000
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
132196000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
148281000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
368000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
55000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
148594000
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
31151000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
66979000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
50464000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
148594000
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2021Q3 crtx Available For Sale Securities Gross Realized Gains Or Losses
AvailableForSaleSecuritiesGrossRealizedGainsOrLosses
0
crtx Available For Sale Securities Gross Realized Gains Or Losses
AvailableForSaleSecuritiesGrossRealizedGainsOrLosses
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62207000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66841000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
52205000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
66979000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
26141000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
50464000
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
472000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
274000
CY2021Q3 crtx Prepaid Insurance Current
PrepaidInsuranceCurrent
1965000
CY2020Q4 crtx Prepaid Insurance Current
PrepaidInsuranceCurrent
964000
CY2021Q3 crtx Prepaid Research And Development Expenses Current
PrepaidResearchAndDevelopmentExpensesCurrent
2083000
CY2020Q4 crtx Prepaid Research And Development Expenses Current
PrepaidResearchAndDevelopmentExpensesCurrent
2110000
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
495000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
694000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5015000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4042000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
875000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
615000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
303000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427000
CY2021Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
2793000
CY2020Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
2415000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
401000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
141000
CY2021Q3 crtx Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
7251000
CY2020Q4 crtx Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
10603000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
829000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
282000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11274000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13441000
CY2018Q2 crtx Number Of Investors
NumberOfInvestors
1
CY2018Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
0
CY2018Q2 crtx Repurchase Option Percentage
RepurchaseOptionPercentage
1
CY2018Q2 crtx Operating Leases Period
OperatingLeasesPeriod
P3Y
CY2019Q2 crtx Operating Lease Payments Paid For Additional Space
OperatingLeasePaymentsPaidForAdditionalSpace
63000
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
0
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
0
CY2020Q2 crtx Operating Lease Termination Month And Year
OperatingLeaseTerminationMonthAndYear
2021-07
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
172000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
172000
crtx Payments For Security Deposit
PaymentsForSecurityDeposit
105000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1200000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
44000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1300
crtx Operating Lease Future Rent Expense
OperatingLeaseFutureRentExpense
1300000
CY2020Q4 crtx Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
557000
CY2021Q3 crtx Accumulated Amortization Of Finance Lease
AccumulatedAmortizationOfFinanceLease
507000
CY2020Q4 crtx Accumulated Amortization Of Finance Lease
AccumulatedAmortizationOfFinanceLease
337000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
50000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
220000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y2M12D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M24D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0188
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0210
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
192000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
756000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
423000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1371000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
24000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1347000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
80400000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y3D
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7618000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4158000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21360000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9511000
crtx Provision For Income Taxes
ProvisionForIncomeTaxes
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5692442000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3768925000

Files In Submission

Name View Source Status
0000950170-21-002495-index-headers.html Edgar Link pending
0000950170-21-002495-index.html Edgar Link pending
0000950170-21-002495.txt Edgar Link pending
0000950170-21-002495-xbrl.zip Edgar Link pending
crtx-20210930.htm Edgar Link pending
crtx-20210930.xsd Edgar Link pending
crtx-20210930_cal.xml Edgar Link unprocessable
crtx-20210930_def.xml Edgar Link unprocessable
crtx-20210930_htm.xml Edgar Link completed
crtx-20210930_lab.xml Edgar Link unprocessable
crtx-20210930_pre.xml Edgar Link unprocessable
crtx-ex10_1.htm Edgar Link pending
crtx-ex31_1.htm Edgar Link pending
crtx-ex31_2.htm Edgar Link pending
crtx-ex32_1.htm Edgar Link pending
crtx-ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending